Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-29 19:05:04 - browse：3118

Adam's take main illustration — Molly Ferguson/STAT

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome.

What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December, Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.

If blarcamesine fails to achieve the pre-determined goals of clinical trials, the thinking apparently goes, then just make a post-hoc change to the study goals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Medicare Advantage proposed rates disappoint insurers

WSS

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Rare Northern Lights show in US this week: Where and how to see it

Why Titanic fascinates society, still drawing tours to the wreckage

Medicare Advantage proposed rates disappoint insurers

A disappointing year of Humira biosimilars

How redistricting in 6 states could affect who controls Congress

hotspot

Wikipedia

Wikipedia

Affirmative action in medical school literally saved lives

Sen. Bill Cassidy on how to lower drug prices

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

US intelligence assessment says Iran not currently developing nuclear weapons

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout LOUD podcast: How biotech is using artificial intelligence

Cancer drug shortages should be causing more outrage

For Medicare Advantage, Democrats want stronger protections around AI

focus

What we’ve learned from the Aduhelm mess

California man arrested in connection with serial murders of Mexican strip club workers

Biden report: The neurospychology of memory and aging

House panel to mark up pandemic

Biden report: The neurospychology of memory and aging

Medicare Advantage proposed rates disappoint insurers

knowledge

focus

explore

hotspot